CVE-2025-7674 Details
Description
Improper Input Validation vulnerability in Roche Diagnostics navify Monitoring allows an attacker to manipulate input data, which may lead to a denial of service (DoS) due to negatively impacting the server's performance. This vulnerability has no impact on data confidentiality or integrity. This issue affects navify Monitoring before 1.08.00.
A denial-of-service vulnerability has been identified in Roche Diagnostics navify Monitoring versions prior to 1.08.00. This issue arises from improper input validation, allowing attackers to manipulate input data in a way that disrupts the server's performance.
Metrics
CVSS 4.0 Severity and Vector Strings:
CVSS 3.x Severity and Vector Strings:
No data available for CVSS Version 2.0 on this CVE.
Volerion
Assessed Aug 5, 2025CISA-ADP
Assessed Aug 5, 2025References to Advisories, Solutions, and Tools
By selecting these links, you will be leaving this site. These are references gathered from the official CVE record and are not endorsed by Volerion.
| URL | Source(s) | Tag(s) |
|---|---|---|
| https://preview-owp.roche.com/content/dam/diagnostics/Blueprint/en/pdf/navify%20Monitoring%20-%20API%20Input%20Validation%20Vulnerability%20-%20Product%20Security%20Advisory.pdf | Roche Diagnostics | AdvisoryPermission RequiredVendor |
Weakness Enumeration
| CWE-ID | CWE Name | Source |
|---|---|---|
| CWE-20 | Improper Input Validation | Roche Diagnostics |
Affected Products
| Product | Versions |
|---|---|
| Roche Diagnostics navify Monitoring | All versions |
CPE
Remediation
| |
Change History
3 change records found show changes
| Date | Action | Recorded By |
|---|---|---|
| Jun 17, 2026 | CVE Modified | Roche Diagnostics |
| Jun 17, 2026 | CVE Modified | CISA-ADP |
| Aug 5, 2025 | New CVE Received | Roche Diagnostics |
Volerion